Related Experiment Video
Updated: Jul 6, 2026

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
Published on: July 11, 2016
Development of a high-throughput MassARRAY-based single assay for the characterization of Streptococcus suis species
Surasak Jiemsup1, Kamonwan Lunha2, Wiyada Chumpol2
1National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Phahonyothin Road, Khlong Luang, Pathum Thani, 12120, Thailand. surasak@biotec.or.th.
Abstract:
Streptococcus suis is a significant porcine pathogen and zoonotic agent responsible for infectious diseases in humans worldwide. It is classified into 29 serotypes, each with varying geographical prevalence and pathogenicity. Hence, serotyping of S. suis is crucial for active surveillance, outbreak monitoring, and infection control. This study developed a novel MassARRAY-based single assay to simultaneously identify S. suis species and differentiate all 29 serotypes. The assay targeted glutamate dehydrogenase (gdh) and recombination/repair protein (recN) for species identification, and capsular polysaccharide (cps) genes for serotyping. Based on single nucleotide polymorphisms (SNPs) at position 483 of cpsK gene, the assay accurately distinguished between two pairs of serotypes: ½ and 2, as well as 1 and 14. The assay, validated with genomic DNA from 105 whole-genome sequencing (WGS)-confirmed isolates, demonstrated 100% specificity and sensitivity for both species identification and serotyping. In the evaluation with 143 field isolates, the results demonstrated perfect agreement between the MassARRAY-based assay and WGS for species identification, with 100% sensitivity and specificity, and for serotyping, with 99.15% sensitivity and 100% specificity (κ-value = 0.98). The agreement between WGS-based serotyping and multiplex PCR serotyping was substantial (κ = 0.65). Moreover, the results showed that the limit of detection for both species and serotypes ranged from 1 to 10 pg of gDNA per reaction.
Insights
A new MassARRAY assay accurately identifies Streptococcus suis and all 29 serotypes. This rapid method aids surveillance and control of this important swine pathogen and zoonotic agent.
Area of Science:
- Veterinary Microbiology
- Molecular Diagnostics
- Public Health
Background:
- Streptococcus suis is a major cause of disease in pigs and humans globally.
- Accurate identification and serotyping of S. suis are vital for disease surveillance and control.
- Current methods can be time-consuming or lack comprehensive coverage of all serotypes.
Purpose of the Study:
- To develop a novel, single MassARRAY-based assay for simultaneous S. suis species identification and differentiation of all 29 serotypes.
- To provide a rapid, accurate, and efficient diagnostic tool for S. suis surveillance.
Main Methods:
- Targeted amplification of glutamate dehydrogenase (gdh) and recombination/repair protein (recN) genes for species identification.
- Targeted amplification of capsular polysaccharide (cps) genes and analysis of single nucleotide polymorphisms (SNPs) for serotyping.
- Validation using genomic DNA from 105 whole-genome sequencing (WGS)-confirmed isolates and 143 field isolates.
Main Results:
- The MassARRAY assay achieved 100% specificity and sensitivity for species identification and serotyping in WGS-validated isolates.
- Evaluation with field isolates showed perfect agreement with WGS for species identification (100% sensitivity/specificity) and high agreement for serotyping (99.15% sensitivity, 100% specificity, κ=0.98).
- The assay demonstrated a low limit of detection (1-10 pg gDNA) and accurately distinguished specific serotype pairs based on SNPs.
Conclusions:
- The developed MassARRAY assay is a highly specific and sensitive tool for simultaneous S. suis species identification and serotyping.
- This novel assay offers a valuable advancement for routine diagnostics, surveillance, and outbreak investigations of S. suis.
- The assay's efficiency and accuracy support improved management of S. suis infections in both animal and human health.

